Figure 1.
Comparison of serum haptoglobin levels (A) between normal healthy controls and NSCLC patients; (B) in normal healthy controls and NSCLC patients at different TNM stage; (C) in NSCLC patients with and without lymph node metastasis; (D) in NSCLC patients with and without distant metastasis.